Cost-effectiveness of midostaurin in the treatment of newly diagnosed FLT3-mutated acute myeloid leukemia in France [0.03%]
米哚妥林治疗法国新诊断的FLT3突变急性髓系白血病的 cost-effectiveness 分析
Gabriel Tremblay,Clemence Cariou,Christian Recher et al.
Gabriel Tremblay et al.
Background: Midostaurin (MIDO) combined with standard chemotherapy was approved by the European Medicines Agency in 2017 for the treatment of adults with newly diagnosed FLT3-mutated acute myeloid leukemia (AML) based on ...
Reply to the comment on "Trends in rates of orthopedic surgery in Germany: the good, the bad, the ugly." [0.03%]
对“德国骨科手术率趋势：好坏美丑”的评论回复
Natalie Baier,Lisa-Marie Sax,Leonie Sundmacher
Natalie Baier
A general framework for classifying costing methods for economic evaluation of health care [0.03%]
保健经济评估分类成本法的通用框架
Zuzana Špacírová,David Epstein,Leticia García-Mochón et al.
Zuzana Špacírová et al.
According to the most traditional economic evaluation manuals, all "relevant" costs should be included in the economic analysis, taking into account factors such as the patient population, setting, location, year, perspective and time horiz...
Advanced therapy medicinal products: value judgement and ethical evaluation in health technology assessment [0.03%]
先进治疗药物：卫生技术评估中的价值判断和伦理评价
Elisabete Gonçalves
Elisabete Gonçalves
Advanced therapy medicinal products (ATMPs) are a heterogeneous class of medicinal products that by offering the potential of cure represent a paradigm shift in the approach of many life-threatening diseases. Although a common regulatory fr...
Livio Garattini,Anna Padula
Livio Garattini
Incorporating self-reported health measures in risk equalization through constrained regression [0.03%]
通过约束回归在风险调节中纳入自我报告的健康指标
A A Withagen-Koster,R C van Kleef,F Eijkenaar
A A Withagen-Koster
Most health insurance markets with premium-rate restrictions include a risk equalization system to compensate insurers for predictable variation in spending. Recent research has shown, however, that even the most sophisticated risk equaliza...
Low risk, high reward? Repeated competitive biddings with multiple winners in health care [0.03%]
低风险，高回报？医疗领域的多重中标竞争性招标机制
Visa Pitkänen,Signe Jauhiainen,Ismo Linnosmaa
Visa Pitkänen
We study physiotherapy providers' prices in repeated competitive biddings where multiple providers are accepted in geographical districts. Historically, only very few districts have rejected any providers. We show that this practice increas...
A comparison of individual and collective decision making for standard gamble and time trade-off [0.03%]
群体与个体的决策对标准博弈和时间交换的影响比较分析研究
Arthur E Attema,Han Bleichrodt,Olivier l&#x;Haridon et al.
Arthur E Attema et al.
Quality-Adjusted Life-Years (QALYs) are typically derived from individual preferences over health episodes. This paper reports the first experimental investigation into the effects of collective decision making on health valuations, using b...
A vision 'bolt-on' increases the responsiveness of EQ-5D: preliminary evidence from a study of cataract surgery [0.03%]
一项视觉补充研究初步表明EQ-5D的灵敏度有所提高：来自白内障手术的研究证据
Mihir Gandhi,Marcus Ang,Kelvin Teo et al.
Mihir Gandhi et al.
Objectives: (1) To evaluate the effect of adding a vision dimension ('bolt-on') to the 5-level EQ-5D (EQ-5D-5L) and 3-level EQ-5D (EQ-5D-3L) on their responsiveness, and (2) to compare the responsiveness of a vision 'bolt...
Cost-effectiveness and budget impact of the microprocessor-controlled knee C-Leg in transfemoral amputees with and without diabetes mellitus [0.03%]
膝关节假肢的成本效益及预算影响：伴有或不伴有糖尿病的股骨截肢患者
Alexander Kuhlmann,Henning Krüger,Susanne Seidinger et al.
Alexander Kuhlmann et al.
Background: The safe use of a prosthesis in activities of daily living is key for transfemoral amputees. However, the number of falls varies significantly between different prosthetic device types. This study aims to comp...